Revolution Medicines (RVMD) Invested Capital (2018 - 2026)

Revolution Medicines' Invested Capital history runs 9 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Invested Capital fell 27.82% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (down 27.82% YoY), while the FY2025 annual figure was $1.6 billion, down 27.98% from the prior year.
• Invested Capital was $1.5 billion for Q1 2026 at Revolution Medicines, down from $1.6 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $2.3 billion in Q4 2024 to a low of $498.8 million in Q2 2022.
• Historically, Invested Capital has averaged $1.3 billion across 5 years, with a median of $1.6 billion in 2024.
• The sharpest annual moves came in 2023 and 2025: Invested Capital soared 166.52% in 2023, then slipped 27.98% in 2025.
• A 5-year view of Invested Capital shows it stood at $685.2 million in 2022, then jumped by 166.52% to $1.8 billion in 2023, then rose by 24.04% to $2.3 billion in 2024, then retreated by 27.98% to $1.6 billion in 2025, then dropped by 8.05% to $1.5 billion in 2026.
• The last three Invested Capital figures came in at $1.5 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.